PEN:NYSE
Penumbra Inc
318,40Â US$
arrow_downward
-0,14%(-0,46) 1K
30-sen, 9:35:21 (GMT-4) · USD
search
Barcha belgilar
1K
5K
1O
6O
YBB
1Y
5Y
MAKS
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoPEN tikeri uchun statistika yaratilmoqda...
Ochish
318,51Â US$
Yuqori
318,51Â US$
Past
318,40Â US$
Bozor kapitali
12,54Â mlrd
Oʻrtacha hajm
343,78Â ming
Hajmi
1,06Â ming
P/E koeffitsiyenti
78,20
52 haftalik eng yuqori
362,41Â US$
52 haftalik eng past
221,26Â US$
Aksiya boʻyicha daromad
4,07Â US$
Beta
0,70
Muomaladagi aksiyalar
39,39Â mln
Xodimlar soni
5Â ming
Ochish
318,51Â US$
Yuqori
318,51Â US$
Past
318,40Â US$
Bozor kapitali
12,54Â mlrd
Oʻrtacha hajm
343,78Â ming
Hajmi
1,06Â ming
P/E koeffitsiyenti
78,20
52 haftalik eng yuqori
362,41Â US$
52 haftalik eng past
221,26Â US$
Aksiya boʻyicha daromad
4,07Â US$
Beta
0,70
Muomaladagi aksiyalar
39,39Â mln
Xodimlar soni
5Â ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Zacks
·
21 soat oldin
IART or PEN: Which Is the Better Value Stock Right Now?
Profil
Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.
In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by year-end. Wikipedia
Penumbra Inc haqida